For the first time results from the CLS-sponsored study at Skåne University Hospital (SUS) will be presented and discussed during an international scientific congress. We are happy to share that the abstract OP033 “Laser interstitial thermal therapy using an uncooled laser catheter in a diagnostic MR suite” by Dr Hjalmar Bjartmarz et al, has been accepted for oral presentation at the ESSFN (European Society of Stereotactic and Functional Neurosurgery) congress in Stockholm, September 28.

The authors write that “Laser interstitial thermal therapy (LITT) has emerged as an alternative to open surgery for both primary and secondary brain tumors. Additionally, thermal ablation by laser can be Laser interstitial thermal therapy (LITT) has emerged as an alternative to open surgery for both primary and secondary brain tumors”. In the study conducted by the team at SUS, five patients with recurrent glioblastoma were included and single or multiple ablations performed.

In the abstract the authors discuss the advantages of using a non-cooled laser catheter system with thermometry (TRANBERG® Laser Applicator and Thermoguide Workstation by CLS), together with a MRI compatible navigation system (ClearPoint® Neuro Navigation System), and how patient risks are minimized using a workflow where both catheter placement and ablation are performed inside a diagnostic MR suite.

Their conclusion is that “LITT using a non-cooled laser catheter inside an outpatient MRI suite was feasible and reproducible. The procedure may reduce risks associated with LITT procedures.”

The full abstract is published on the ESSFN website (search speaker: Bjartmarz):

https://essfncongress.org/programme/